Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies
BackgroundAt the beginning of the SARS-CoV-2 pandemic, there was a lack of information about the infection’s impact on pregnancy and capability to induce de novo autoantibodies. It soon became clear that thrombosis was a manifestation of COVID-19, therefore the possible contribution of de novo antip...
Main Authors: | Giorgia Ingrid Gozzoli, Elda Piovani, Beatrice Negri, Margaret Mascherpa, Rossana Orabona, Cristina Zanardini, Sonia Zatti, Silvia Piantoni, Maria Grazia Lazzaroni, Cesare Tomasi, Federico Prefumo, Enrico Sartori, Franco Franceschini, Angela Tincani, Laura Andreoli |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.953043/full |
Similar Items
-
Anti-Phosphatidylserine/Prothrombin Antibodies at Two Points: Correlation With Lupus Anticoagulant and Thrombotic Risk
by: Natalia Egri, et al.
Published: (2021-10-01) -
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome
by: Maria Orietta Borghi, et al.
Published: (2020-10-01) -
Prevalence, clinical significance, and persistence of autoantibodies in COVID-19
by: Se Ju Lee, et al.
Published: (2023-10-01) -
Bilateral pleural effusion with APLA positivity in a case of rhupus syndrome
by: Kaushik Saha, et al.
Published: (2014-01-01) -
Investigating the Status of Antiphospholipid Antibodies in Patients with Mild COVID-19
by: Farshid Mohammadi, et al.
Published: (2023-12-01)